Anke Höllig
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (9)
Background Delayed cerebral ischemia represents a significant contributor to death and disability following aneurysmal subarachnoid hemorrhage. Although preclinical models have shown promising results, clinical trials have consistently failed to replicate the success of therapeutic strategies. The lack of standardized experimental setups and outcome assessments, particularly regarding secondary vasospastic/ischemic events, may be partly responsible for the translational failure. The study aims to delineate the procedural characteristics and assessment modalities of secondary vasospastic and ischemic events, serving as surrogates for clinically relevant delayed cerebral ischemia, in recent rat and murine subarachnoid hemorrhage models. Methods and Results We conducted a systematic review of rat and murine in vivo subarachnoid hemorrhage studies (published: 2016–2020) using delayed cerebral ischemia/vasospasm as outcome parameters. Our analysis included 102 eligible studies. In murine studies (n=30), the endovascular perforation model was predominantly used, while rat studies primarily employed intracisternal blood injection to mimic subarachnoid hemorrhage. Particularly, the injection models exhibited considerable variation in injection volume, rate, and cerebrospinal fluid withdrawal. Peri‐interventional monitoring was generally inadequately reported across all models, with body temperature and blood pressure being the most frequently documented parameters (62% and 34%, respectively). Vasospastic events were mainly assessed through microscopy of large cerebral arteries. In 90% of the rat and 86% of the murine studies, only male animals were used. Conclusions Our study underscores the substantial heterogeneity in procedural characteristics and outcome assessments of experimental subarachnoid hemorrhage research. To address these challenges, drafting guidelines for standardization and ensuring rigorous control of methodological and experimental quality by funders and journals are essential. Registration URL: https://www.crd.york.ac.uk/prospero/ ; Unique identifier: CRD42022337279.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (8)
Arno Reich
-
Rahul Raj
-
Martin Wiesmann
University Hospital RWTH Aachen
Omid Nikoubashman
-
Miikka Korja
University of Helsinki
Jyri Virta
Helsinki University Hospital
Jarno Satopää
University of Helsinki
Mark Coburn
Professor and Chair
University Hospital Bonn
Make your next move.
Prepare your application
Review drafts before you send them.